Literature DB >> 10760728

Desmoplastic malignant melanoma of the palatal alveolar mucosa: sustained disease-free survival after surgery and postoperative radiotherapy.

B D Kavanagh1, R L Campbell, J W Patterson, R L O'Neill, R M Cardinale, G E Kaugars.   

Abstract

Aggressive surgical and radiotherapeutic management of a patient with desmoplastic malignant melanoma arising from the mucosa of the oral cavity has resulted in disease-free survival of more than 2(1/2) years after diagnosis. This case represents only the tenth reported instance of desmoplastic malignant melanoma arising from the oral cavity and only the third for which survival has exceeded 2 years. Details of the clinical, histopathologic, and therapeutic features of the case are provided to augment the paucity of literature available to clinicians managing this rare disease.

Entities:  

Mesh:

Year:  2000        PMID: 10760728     DOI: 10.1016/s1079-2104(00)70126-0

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  4 in total

1.  Genetic markers of oral malignant melanoma analysed by fluorescence in situ hybridisation (FISH).

Authors:  Chiara Baldovini; Anna L Tosi; Enrico Di Oto; Camilla Reggiani; Susanna Cappia; Christine M Betts; Carmine Gallo; Lisa Ricchieri; Roberto Cocchi; Maria P Foschini
Journal:  Virchows Arch       Date:  2011-06-29       Impact factor: 4.064

2.  [Pigmented lesions of the oral mucosa].

Authors:  J Beck-Mannagetta; G Hutarew
Journal:  Hautarzt       Date:  2012-09       Impact factor: 0.751

3.  Desmoplastic melanoma of the oral cavity: diagnostic pitfalls and clinical characteristics.

Authors:  Seung-Ki Min; Joo Hee Jeong; Kang-Min Ahn; Chong Woo Yoo; Joo Yong Park; Sung Weon Choi
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2018-04-25

4.  Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma.

Authors:  William G Rule; Jacob B Allred; Barbara A Pockaj; Svetomir N Markovic; David J DiCaudo; Lori A Erickson; Richard L Deming; Steven E Schild
Journal:  Cancer Med       Date:  2016-07-01       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.